It’s the simple additions to your service that improve patient satisfaction, start offering medicines delivery to all of them today
Oct 01, 2026 Weight Loss
When considering medical treatment for weight management, understanding the differences between available medications can help you make an informed decision alongside your healthcare provider.
Both the oral semaglutide tablet (commonly known as the Wegovy Pill) and injectable tirzepatide (Mounjaro) are licensed, effective prescription options in the UK. However, they differ significantly in their active ingredients, how they interact with gut hormones, their administration routes, and their storage requirements.
The fundamental difference between these two treatments lies in their underlying pharmacology and active ingredients.
The Wegovy Pill contains the same active ingredient as the Wegovy weekly injection. Semaglutide, which is a GLP-1 receptor agonist. GLP-1 is a gut hormone that naturally occurs when we eat. Semaglutide mirrors the naturally forming GLP-1 hormone and binds to GLP-1 receptors in the brain, increasing feelings of fullness, reducing hunger, and slowing down gastric emptying.
Mounjaro contains tirzepatide, which is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist. By targeting two distinct gut hormone pathways simultaneously, tirzepatide works to regulate your appetite (resulting in a lower calorie intake), increase insulin sensitivity, and help with weight loss.
How a medication is taken and stored often plays a major role in choosing a treatment that fits seamlessly into your daily routine.
| The Wegovy Pill (Daily Oral Semaglutide) | Mounjaro (Weekly Injectable Tirzepatide) | |
|---|---|---|
| Active Ingredient | Semaglutide | Tirzepatide |
| How it Works | Single GLP-1 receptor agonist | Dual GIP / GLP-1 receptor agonist |
| How it is Taken | Oral daily tablet | Subcutaneous weekly injection |
| Frequency | Once daily, every morning | Once weekly, on the same day each week |
| Dosing Conditions | Must be taken first thing in the morning on an empty stomach. Take with water (no more than 120ml). Do not eat, drink or take any other medications for 30 minutes after taking the Wegovy Pill. |
Can be taken at any time of day, with or without food. |
| Storage Requirements | Store at room temperature (below 30°C) in the original blister pack to protect from moisture. No refrigeration required. | Prior to first use, store in a refrigerator (2°C to 8°C). Once in use, can be kept at room temperature (below 30°C) for up to 30 days. |
| Dose Escalation | A monthly increase starting at the lowest strength of 1.5mg. | A monthly increase starting at 2.5mg up to a maximum maintenance dose. |
Find out more about weight loss pills, including GLP-1 tablets, and the options available.
Oral semaglutide requires strict adherence to daily dosing instructions because the tablet relies on an absorption enhancer (SNAC) to help the active peptide pass through the stomach lining. It must be taken immediately upon waking with a small sip of plain water (no more than 120ml). You must then wait at least 30 minutes before consuming any food, hot drinks, or other medications, as any presence of food or excess liquid in the stomach drastically reduces absorption.
Mounjaro is supplied as a pre-filled multi-dose pen injected under the skin (subcutaneously) into the abdomen, thigh, or upper arm once a week. Because it bypasses the digestive tract entirely, weekly administration is flexible regarding food, drink, and time of day.
Both treatments are backed by clinical trials demonstrating significant average weight loss when combined with reduced-calorie diet plans and increased physical activity.
Because individual responses to GLP-1 and GIP/GLP-1 receptor agonists vary based on metabolic health, genetics, and adherence, neither medication can be categorised as universally superior for every patient. Treatment choice should be guided by clinical suitability, medical history, tolerability, and individual preference.
Both medications share similar gastrointestinal side effect profiles, particularly when starting treatment or escalating to a higher dose. The most frequently reported effects include:
For both options, side effects are usually short-lived and settle as your body adapts to the medication.
Choosing between an oral daily tablet and a weekly injection comes down to personal lifestyle preferences and clinical suitability.
You prefer the convenience of a once-weekly dose rather than remembering a daily medication every morning.
You find strict morning dietary restrictions difficult to maintain due to shift work or busy schedules.
You prefer a flexible administration schedule that is unaffected by food or drink intake.
Patients currently taking Mounjaro may be eligible to switch to the Wegovy Pill following a thorough clinical evaluation by a healthcare professional.
Switching requires careful attention to dose conversion to ensure treatment continuity while minimising gastrointestinal side effects. You should never adjust your dose or switch treatments without formal clinical approval and guidance from your prescriber.
When transitioning from injectable tirzepatide (Mounjaro) to oral semaglutide (Wegovy Pill), prescribers align current dosage strengths using established clinical conversion pathways:
| Current Mounjaro Dose | Equivalent Wegovy Pill Starting Dose |
|---|---|
| 2.5mg weekly | 4mg daily |
| 5mg weekly | 4mg daily |
| 7.5mg weekly | 9mg daily |
| 10mg or higher weekly | 25mg daily |
You can find the official clinical administration instructions and conversion guidance on the official Wegovy Pill information portal.
Both Wegovy Pill and Mounjaro are safe, effective clinical interventions for weight management when prescribed appropriately. Finding the right option depends on your health profile, previous experience with weight loss medications, and personal preference regarding daily tablets versus weekly injections.
To determine which treatment is most appropriate for you, complete our brief, confidential online consultation. Our UK-registered clinical team will evaluate your medical history, current BMI, and lifestyle requirements to ensure your selected treatment is safe and suitable.
The primary differences lie in their active ingredients, how they work, and how they are administered. The Wegovy Pill (GIP) containing semaglutide is taken first thing every morning on an empty stomach. Mounjaro contains tirzepatide (a dual GIP/GLP-1 receptor agonist) and is a weekly subcutaneous injection.
Neither treatment is definitively better for every individual. Both medications demonstrate strong efficacy in clinical trials when paired with diet and exercise modifications. The best choice depends on your clinical suitability, lifestyle preferences, tolerance of side effects, and whether you prefer a daily tablet or a weekly injection.
Both oral semaglutide and injectable tirzepatide have demonstrated significant weight loss outcomes in published clinical studies. Effectiveness varies between individuals based on dose, metabolic health, and lifestyle changes. Your clinician can help explain expected outcomes based on your health background and current information.
Transitioning from Mounjaro to the Wegovy Pill is possible following an online clinical consultation or assessment. A prescriber will review your current Mounjaro dose and match it to the appropriate starting strength of the Wegovy Pill to ensure a safe transition.
Dose conversions depend directly on your current Mounjaro strength. For example, a 2.5mg weekly Mounjaro dose typically transitions to a 4mg daily Wegovy Pill, while higher strengths move to 4mg, 9mg, or 25mg daily doses. Always consult a prescriber before switching.
No. The Wegovy Pill contains semaglutide, whereas Mounjaro contains tirzepatide. While both target GLP-1 pathways, tirzepatide also targets GIP receptors. For those interested in injectable semaglutide options, refer to our page on Wegovy injections.
For patients who dislike needles, an oral tablet may feel simpler. However, the Wegovy Pill requires strict daily compliance, including taking it first thing in the morning with a small sip of water and waiting 30 minutes before consuming food or drinks. Some patients find a once-weekly injection easier to maintain.
You do not need prior experience with Mounjaro or any other weight loss injection to start the Wegovy Pill. Patients new to GLP-1 treatments begin on the lowest dose (1.5mg) and gradually step up monthly.
No. Unlike Mounjaro pens, which require refrigeration before first use, the Wegovy Pill is stored at room temperature (below 30°C) in its original blister packaging to protect it from moisture.
Both medications carry similar potential side effects, primarily involving the digestive system (nausea, constipation, bloating, and mild indigestion). Tolerability varies by individual rather than by medication choice.
If you find the daily dosing routine of the Wegovy Pill inconvenient or experience persistent side effects, you can request a clinical review to discuss switching back to an injectable option like Mounjaro.
Consider your daily schedule, willingness to self-inject versus swallowing a daily tablet, storage needs, and ability to follow fasting rules. Completing an online health questionnaire allows our pharmacist prescriber to assess your medical suitability and recommend the safest pathway.
When considering medical treatment for weight mana... Read More..
Understanding potential side effects is an essenti... Read More..
A brand-new daily prescription weight-management m... Read More..
Weight-loss injections and tablets, including GLP-... Read More..
Taking care of your sexual health is an essential... Read More..
Managing adult blemishes alongside fine lines can... Read More..
It’s the simple additions to your service that improve patient satisfaction, start offering medicines delivery to all of them today